SKLICE (ivermectin) Lotion, 0.5%, prescribing information, NDA 202736 (initial approval label) (2012)

Government Record · Sanofi Pasteur, Inc. (label as approved 02/2012); marketer now Azurity Pharmaceuticals · February 2012

Sanofi Pasteur et al., 2012-02: The FDA approval label for topical 0.5% ivermectin lotion for head lice, a single 10-minute application rinsed off with water, for patients 6 months and older.

SKLICE Lotion is a pediculicide indicated for the topical treatment of head lice infestations in patients 6 months of age and older.

1

Sanofi Pasteur et al., 2012-02: The FDA approval label for topical 0.5% ivermectin lotion for head lice, a single 10-minute application rinsed off with water, for patients 6 months and older. Regulatory label for the pivotal-approval product; single-use, topical, up to one tube to coat dry hair, left 10 minutes, rinsed, no nit combing required per label. Label notes 'Initial U.S. Approval: 1996' (the oral NDA) and is marked 'This label may not be the latest approved by FDA'. The product is now marketed on an OTC Drug Facts label by Azurity Pharmaceuticals (DailyMed setid 7579bdfe-a538-4bff-b7c7-df2c4b6f13db, 'Use: treats head lice', active ingredient ivermectin 0.5%). Pivotal trial is IVE-10 (Pariser 2012). Study type: regulatory record.